Literature DB >> 12478120

The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.

Jean O Ung1, Ignacio F San Francisco, Meredith M Regan, William C DeWolf, Aria F Olumi.   

Abstract

PURPOSE: We investigated the relationship between prostate volume and cancer detection by needle biopsy, and determined the effect of an increased number of cores on the sampling error of needle biopsy on large prostate glands.
MATERIALS AND METHODS: The study cohort included 750 consecutive patients who underwent first time transrectal ultrasound guided prostate needle biopsy from January 1995 to August 2001. Prostate volumes were divided into quartiles (13 to 34, 34.1 to 45, 45.1 to 64 and 64.1 to 244 cc). Multivariate analysis controlling for age, prostate specific antigen (PSA) and biopsy indication was performed to determine the effect of the number of cores and prostate volume on prostate cancer detection.
RESULTS: Patients diagnosed with prostate cancer were older (p = 0.0035) and had higher PSA levels (p = 0.0002) than those with no cancer on biopsy. Decreasing cancer detection rates were seen with increasing prostate volume (p = 0.0074). The OR of detection for each additional core was 0.99 (95% CI 0.93, 1.06), suggesting that increasing the number of biopsy cores did not increase the rate of prostate cancer detection. Multivariate analysis revealed that patients with larger prostates had the same, or possibly lower, cancer detection rate as the number of biopsy cores was increased. Patients with larger prostates were older (p <0.0001), had higher PSA levels (p <0.0001) and were even more likely to have undergone biopsy for increased PSA rather than abnormal digital rectal examination alone (p <0.0001).
CONCLUSIONS: Our study suggests that the lower cancer detection rate for men with large prostates may be due to a decrease in the use of increased serum PSA for prostate cancer detection in larger prostates in addition to other factors such as sampling error. Increased serum PSA levels in cases of larger prostates, although a risk factor for prostate cancer warranting biopsy, may also be due to nonmalignant sources such as benign prostatic hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12478120     DOI: 10.1097/01.ju.0000034153.49106.b7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

Review 1.  Strategies for repeat prostate biopsies.

Authors:  Martha K Terris
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

2.  Possible clinical implications of peripheral zone changes depending on prostate size.

Authors:  Joshua M Frost; Lisa A Smith; Pranav Sharma; Werner T de Riese
Journal:  Int Urol Nephrol       Date:  2019-07-18       Impact factor: 2.370

3.  Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view.

Authors:  Shadi Khalil; Werner de Riese
Journal:  World J Urol       Date:  2017-03-17       Impact factor: 4.226

4.  Comparison of 8, 10, 12, 16, 20 cores prostate biopsies in the determination of prostate cancer and the importance of prostate volume.

Authors:  Cavit Ceylan; Omer Gokhan Doluoglu; Erdogan Aglamis; Ozkan Baytok
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

5.  The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer.

Authors:  Mohamed Amine Jradi; Mohamed Dridi; Mourad Teyeb; Mokhtar Ould Sidi Mohamed; Ramzi Khiary; Samir Ghozzi; Nawfel Ben Rais
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

6.  Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.

Authors:  Guillermo Lorenzo; Thomas J R Hughes; Pablo Dominguez-Frojan; Alessandro Reali; Hector Gomez
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-07       Impact factor: 11.205

7.  The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach.

Authors:  B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

8.  The importance of prostate volume in prostate needle biopsy.

Authors:  Ömer Gökhan Doluoğlu; Çetin Volkan Öztekin; Mehmet Karabakan; Alp Özgür Akdemir; Mesut Çetinkaya
Journal:  Turk J Urol       Date:  2013-06

9.  Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.

Authors:  Shadi Al-Khalil; David Boothe; Trey Durdin; Sowmya Sunkara; Phillip Watkins; Shengping Yang; Allan Haynes; Werner de Riese
Journal:  Int Urol Nephrol       Date:  2015-11-21       Impact factor: 2.370

10.  Detection rate of prostate cancer on the basis of the vienna nomogram: a singapore study.

Authors:  Jin Kiat Teo; Beow Kiong Poh; Foo Cheong Ng; Yan Kit Fong
Journal:  Korean J Urol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.